Media Digest 3/3/2010 Reuters, WSJ, NYTimes, FT, Bloomberg

Print Email

Reuters:   The Senate overcame opposition to allow jobless benefits to be extended.

Reuters:   China will hope to keep the value of the yuan steady.

Reuters:   JC Penney (JCP) will focus on exclusive products.

Reuters:   Disney (DIS) is the bully in a program dispute says Cablevision (CVC).

Reuters:   Apple (AAPL) sued HTC over patent violations.

Reuters:   US regulators are looking at hedge fund bets against the euro.

Reuters;   Fed officials are at odds about whether to keep rates low for a long period.

Reuters:   Toyota (TM) is still under pressure from lawmakers over data on recalls.

WSJ:   Millions of homeowners have missed out on low mortgage rates because they can’t or won’t refinance.

WSJ:   Strong Ford (F) sales are putting heat on GM.

WSJ:   The Administration may suggest a brake overhaul on many cars sold in the US.

WSJ:   Bristol-Myers (BMY) named a new CEO.

WSJ:   Nissan will recall some US cars.

WSJ:   Tivo (TIVO) will release new video recorders.

WSJ:   Wal-Mart (WMT) settled a gender discrimination suit.

WSJ:   Video gamemakers are being hurt by pirates in China.

WSJ:   European nations ignored Greece’s financial problems for years.

WSJ:   The number of retail bank branches may fall for the first time since 2002.

WSJ:   China Merchants Bank will sell shares to raise money.

WSJ:   Hedge funds made a bid to buy Novell.

NYT:   The AFL-CIO will try to cut Republican gains in the midterm elections.

NYT:   UK debts could cause a double dip recession in the country.

NYT:   Viacom (VIA) will take programs off Hulu.

NYT:   GM will triple its investment in an Opel turnaround.

FT:   Citigroup (C) will sell its stake in Primerica.

FT:   GM blamed its recall on a Toyota (TM) supplier.

FT:   Prudential’s shares have fallen 20% since its decision to buy AIG’s (AIG) Asia insurance operations.

Bloomberg:   Greece will detail $6.5 billion in budget cuts.

Bloomberg:   Pfizer (PFE) will offer $4 billion for German generic-drug maker Ratiopharm GmbH,

Douglas A. McIntyre

RSS Facebook Twitter